(4R,5R)-3-oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylic acid

We are (4R,5R)-3-oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylic acid CAS:862174-60-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 862174-60-5
Product Name: (4R,5R)-3-oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylic acid
Other Name:
(4R,5R)-3-oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylic acid
3-Oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylic acid
 
Density: 1.5±0.1 g/cm3
Boiling Point: 422.0±38.0 °C at 760 mmHg
Molecular Formula: C7H8O4
Molecular Weight: 156.136
Flash Point: 186.1±20.3 °C
Exact Mass: 156.042252
PSA: 63.60000
LogP: -1.18
Vapour Pressure: 0.0±2.1 mmHg at 25°C
Index of Refraction: 1.552
 
Specification
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Simeprevir CAS: 923604-59-5.
Be used as pharmaceutical intermediate, mainly used to synthesize antihepatitis C drugs Simeprevir.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

(4R,5R)-3-oxo-2-oxabicyclo[2.2.1]heptane-5-carboxylic acid


Related News: The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.5-cloro-4-metoxi-2-oxo-1,2-dihidropiridin-3-carbonitrilo CAS:147619-40-7 The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.4-Chloro-2-fluorobenzaldehyde With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.Ácido 5- (4-fluorofenil) -5-oxopentanoico CAS:149437-76-3 With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.

Related Products
Product Name
2-Amino-6-chloropurine-9-riboside View Details
(3-dibenzothiophen-4-ylphenyl)boronic acid View Details
Cytidylic acid View Details
hexamethyldisiloxane manufacturer 3,4-Dihydroxybenzaldehyde manufacturer (R)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran manufacturer 1-octyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide manufacturer CAS:2602-34-8 CoatOSil 2287 manufacturer